Old Web
English
Sign In
Acemap
>
Paper
>
P2.12-13 Lurbinectedin (L) Combined with Paclitaxel (P) or Irinotecan (I) in Relapsed SCLC. Results from Two Phase Lb Trials
P2.12-13 Lurbinectedin (L) Combined with Paclitaxel (P) or Irinotecan (I) in Relapsed SCLC. Results from Two Phase Lb Trials
2019
Santiago Ponce
Emiliano Calvo
M. J. de Miguel
C. Sessa
María José Flor
A. Drilon
A. Falcon
I. Sánchez Simón
Rafael Núñez
X.E. Luepke
N. Cuevas-Melendez
J. Lopez-Vilariño
S. Fudio
Mariano Siguero
M. Cullell-Young
Carmen Kahatt
Ali Zeaiter
L. Paz-Ares
Keywords:
Pathology
Oncology
Irinotecan
Lurbinectedin
Medicine
Internal medicine
Paclitaxel
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]